Joshua Silverman
CEO, President at PharmaCyte Biotech, Inc. (PMCB)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-17.9%
vs. S&P 500-13.8%
Beat the market0%
Paper profit on buys−$40K
Total bought / sold$80K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 7SEC | PMCBPharmaCyte Biotech, Inc. | Buy | 30,000346,250 held (+9%) | $0.78 | $23K | -48.2% |
| Jan 7SEC | PMCBPharmaCyte Biotech, Inc. | Buy | 30,000376,250 held (+9%) | $0.79 | $24K | -48.8% |
| Jan 7SEC | PMCBPharmaCyte Biotech, Inc. | Buy | 40,000416,250 held (+11%) | $0.83 | $33K | -51.3% |
- Buy
CEO, President Joshua Silverman bought $23K of PMCB at $0.78 — first open-market purchase in our records.
- Buy
CEO, President Joshua Silverman bought $33K of PMCB at $0.83 — largest purchase by this insider in our records.